Galanin(1-13)-Gln14-bradykinin(2-9)amide is a chimeric peptide combining two bioactive domains to explore multi-motif interaction principles. Its hybrid sequence supports conformational and receptor-binding studies. Aromatic and charged residues create diverse interaction surfaces. Researchers apply it to probe modular peptide engineering.
CAT No: R0884
CAS No:860790-38-1
Synonyms/Alias:860790-38-1;M617;GLY-TRP-THR-LEU-ASN-SER-ALA-GLY-TYR-LEU-LEU-GLY-PRO-GLN-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG-NH2;M617 acetate;M617 TFA;KJB79038;AKOS024457245;DA-55143;PD079343;TS-10546;Alternative Name: Galanin(1-13)-Gln14-bradykinin(2-9)amide;
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
2. Cationic cell-penetrating peptides are potent furin inhibitors
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.